Abiopharma

🔍 Lau Michele (Executive)

Company: MCKESSON CORP (MCK)

Report Date: 2026-02-09

Detailed Transactions and Holdings:

• Acquired 3,990 shares of Common Stock (Direct)
  Date: 2026-02-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 7,237.00 | transaction_form_type: 4
• Sold 1,421 shares of Common Stock at $962.32 per share (Direct)
  Date: 2026-02-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 5,816.00 | transaction_form_type: 4 | Footnotes: F1
• Acquired 758 shares of Common Stock (Direct)
  Date: 2026-02-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 6,574.00 | transaction_form_type: 4
• Sold 299 shares of Common Stock at $962.32 per share (Direct)
  Date: 2026-02-09 | Code: F | equity_swap_involved: 0 | shares_owned_after: 6,275.00 | transaction_form_type: 4 | Footnotes: F1
• Holds 0 shares of Common Stock (Direct)
  Date: 2026-02-09 | Code: H | nature_of_ownership: By the McKesson Corporation 401(k) Retirement Savings Plan | shares_owned_after: 138.62
• Sold 3,990 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-02-09 | Code: M | equity_swap_involved: 0 | transaction_form_type: 4 | Footnotes: F2, F2
• Sold 758 shares of Restricted Stock Units (RSUs) (Derivative)
  Date: 2026-02-09 | Code: M | equity_swap_involved: 0 | shares_owned_after: 758.00 | transaction_form_type: 4 | Footnotes: F3, F3

Footnotes:

• F1: This transaction represents a withholding of shares to cover taxes applicable to a vesting of RSUs also reported on this Form 4.
• F2: These RSUs vested 50% on 2/9/2025 and 50% on 2/9/2026.
• F3: These RSUs vested 1/3 on 2/9/2025 and 1/3 on 2/9/2026, and will vest 1/3 on 2/9/2027.